Pharma Focus Asia

MGI Tech and SeqOne Collaborate to Advance Complete Genomic Analysis

Monday, June 17, 2024

MGI Tech Co., Ltd. and its affiliates have announced a collaboration with SeqOne, a leader in AI-driven genomic decision support software. This partnership is focused on creating and validating comprehensive genomic analysis solutions designed specifically for Human Genetics and Pathology laboratories globally.

The collaboration will focus on three primary projects:

Validation of an Automated HRD Testing Solution: This project will include a joint effort with Agilent Technologies and a Pathology Reference Lab in Spain to validate a cost-effective, automated workflow. This workflow will utilize Agilent panels, Magnis library preparation automation, MGI’s DNBSEQ-G99 sequencing platform, and SeqOne’s validated HRD signature solution on 96 samples. The goal is to provide a high-quality, efficient, and adaptable solution for HRD testing, including genomic instability scores and BRCA testing.

Integration of SeqOne’s Analysis Platform with MGI’s MegaBOLT: The collaboration will work on ensuring that SeqOne’s tertiary analysis platform is compatible with MGI’s MegaBOLT, a bioinformatics analysis accelerator developed by MGI. This integration aims to offer a seamless, cost-effective, and intuitive solution from sample collection to final reporting, particularly suited for high-throughput Human Genetics labs.

Validation of SeqOne’s CE-IVD Platform for Clinical Use: This initiative will evaluate the compatibility of SeqOne’s CE-IVD Platform with MGI sequencers, focusing on variant calling performance with a set of reference control samples in terms of quality control, sensitivity, and precision.

MGI Europe and Africa, expressed enthusiasm about the collaboration, stating, "Combining MGI's advanced sequencing technologies with SeqOne's innovative genomic analysis platform allows us to provide significant insights and solutions for personalized healthcare. This partnership underscores our commitment to advancing genomic research and providing clinicians with the tools necessary for customized patient care."

SeqOne, remarked, "Our partnership with MGI supports SeqOne’s mission to enhance access to advanced genomic analysis, aiming to improve healthcare outcomes. Integrating SeqOne’s CE-IVD Platform with MGI's technologies will enhance the quality, sensitivity, and precision of bioinformatic analyses."

Together, MGI and SeqOne aim to revolutionize genomic diagnostics, offering innovative solutions to laboratories worldwide.

 

Source: prnewswire.com

magazine-slider-imageMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference